Emergency Preparedness Plan:
... Ebola is one of numerous Viral Hemorrhagic Fevers (VHFs). It is a severe, often fatal disease in humans and nonhuman primates (such as monkeys, gorillas, and chimpanzees). Ebola is caused by infection with a virus of the family Filoviridae, genus Ebolavirus. The first Ebolavirus species was discover ...
... Ebola is one of numerous Viral Hemorrhagic Fevers (VHFs). It is a severe, often fatal disease in humans and nonhuman primates (such as monkeys, gorillas, and chimpanzees). Ebola is caused by infection with a virus of the family Filoviridae, genus Ebolavirus. The first Ebolavirus species was discover ...
The Wise List 2015
... disseminate and gain support for evidence-based recommendations among prescribers in SCC primary care, specialised outpatient care and inpatient care in different hospitals. The DTC also works towards the wise introduction of new and effective medicines. By providing continuing medical education, mo ...
... disseminate and gain support for evidence-based recommendations among prescribers in SCC primary care, specialised outpatient care and inpatient care in different hospitals. The DTC also works towards the wise introduction of new and effective medicines. By providing continuing medical education, mo ...
Critical Limb Ischemia Compendium (CLIC
... therefore is not familiar with the latest techniques. Overall, there is a widespread lack of knowledge and an attachment to old ways that needs to be overcome. Unfortunately, data-driven clinical studies do not exist that evaluate strategies for surveillance; use and duration of ...
... therefore is not familiar with the latest techniques. Overall, there is a widespread lack of knowledge and an attachment to old ways that needs to be overcome. Unfortunately, data-driven clinical studies do not exist that evaluate strategies for surveillance; use and duration of ...
Physical Medicine & Rehabilitation Evidence
... with her physician to discontinue Hx: breast cancer and heart disease Dx: re-experiencing symptoms of hot flushes, mood swings, and night sweats. Tx: was treated with HRT. PtQ: Black Cohosh, Red Clover, and Estroven relieve menopausal symptoms; risk of breast cancer and heart disease ...
... with her physician to discontinue Hx: breast cancer and heart disease Dx: re-experiencing symptoms of hot flushes, mood swings, and night sweats. Tx: was treated with HRT. PtQ: Black Cohosh, Red Clover, and Estroven relieve menopausal symptoms; risk of breast cancer and heart disease ...
Prevention and Treatment of Tuberculosis Among Patients Infected with Human Immunodeficiency Virus:
... therapy and revised recommendations. MMWR 1998;47(No. RR-20):[inclusive ...
... therapy and revised recommendations. MMWR 1998;47(No. RR-20):[inclusive ...
PDF Version - Cardiological Society of India
... •• Rapid onset of action: Peak onset 1–4 hours; all of them thus act more or less immediately over the same time course as the low-molecular-weight heparin (LMWH). •• Fixed dose: They can be given in fixed doses. There is no effect of dietary vitamin K intake on the pharmacological activities of the ...
... •• Rapid onset of action: Peak onset 1–4 hours; all of them thus act more or less immediately over the same time course as the low-molecular-weight heparin (LMWH). •• Fixed dose: They can be given in fixed doses. There is no effect of dietary vitamin K intake on the pharmacological activities of the ...
NAEPP 2007 Asthma Guideline UPDATE
... risk for assessing severity and control emphasizes the need to consider separately asthma’s effects on quality of life and functional capacity on an ongoing basis and the risks it presents for adverse events in the future, such as exacerbations and progressive loss of pulmonary function. ...
... risk for assessing severity and control emphasizes the need to consider separately asthma’s effects on quality of life and functional capacity on an ongoing basis and the risks it presents for adverse events in the future, such as exacerbations and progressive loss of pulmonary function. ...
What is the risk of gastrointestinal bleeding associated with selective
... SSRIs and NSAIDs (OR 0.98;95% CI: 0.51-1.88). This effect was also observed in a case-control study by de Abajo et al (2008) (20), which was included in the metaanalysis by Jiang et al (2015) (6). De Abajo et al (2008) found that, without GI protection, an upper GI bleed would be experienced by one ...
... SSRIs and NSAIDs (OR 0.98;95% CI: 0.51-1.88). This effect was also observed in a case-control study by de Abajo et al (2008) (20), which was included in the metaanalysis by Jiang et al (2015) (6). De Abajo et al (2008) found that, without GI protection, an upper GI bleed would be experienced by one ...
Medical Management Guideline
... individualized case-by-case review and medical necessity determination for each PacifiCare member. Member benefit coverage and limitations may vary based on the member’s benefit plan. This medical management guideline is intended for use by PacifiCare employees, PacifiCare contracted providers, and ...
... individualized case-by-case review and medical necessity determination for each PacifiCare member. Member benefit coverage and limitations may vary based on the member’s benefit plan. This medical management guideline is intended for use by PacifiCare employees, PacifiCare contracted providers, and ...
Influence of body mass index on the M. Peters-Golden*, A. Swern
... including response to therapy. The present authors examined whether body mass index (BMI) influenced the response to placebo, as well as to two asthma controller medications. A post hoc analysis was performed, pooling data from four double-blind, placebo-controlled studies randomising 3,073 moderate ...
... including response to therapy. The present authors examined whether body mass index (BMI) influenced the response to placebo, as well as to two asthma controller medications. A post hoc analysis was performed, pooling data from four double-blind, placebo-controlled studies randomising 3,073 moderate ...
$doc.title
... b. Qualitative immuno-‐assay detection of the cocaine metabolite benzoylecgonine in the urine is the most commonly used laboratory method i. Cocaine can also be detected in the blood or hair c. Cocaine use ...
... b. Qualitative immuno-‐assay detection of the cocaine metabolite benzoylecgonine in the urine is the most commonly used laboratory method i. Cocaine can also be detected in the blood or hair c. Cocaine use ...
Guidance for Industry Irritable Bowel Syndrome — Clinical Evaluation of Products for Treatment
... recommend the development of a multi-item PRO instrument that captures all of the clinically important signs and symptoms of IBS. Prospectively defined changes in the scores measured by this PRO instrument between treatment arms should be used as the primary endpoint in IBS clinical trials. The inst ...
... recommend the development of a multi-item PRO instrument that captures all of the clinically important signs and symptoms of IBS. Prospectively defined changes in the scores measured by this PRO instrument between treatment arms should be used as the primary endpoint in IBS clinical trials. The inst ...
Overview of the Final Nursing Home Survey Guidelines
... The facility must: – Provide routine and emergency medications and biologicals to its residents, or obtain them under an agreement – Provide pharmaceutical services including procedures that assure the accurate acquiring, receiving, dispensing, and administering of all medications and biologicals to ...
... The facility must: – Provide routine and emergency medications and biologicals to its residents, or obtain them under an agreement – Provide pharmaceutical services including procedures that assure the accurate acquiring, receiving, dispensing, and administering of all medications and biologicals to ...
Audit of Lower Gastrointestinal Bleeding and the Use of Blood
... and anorectal bleeding. There is some evidence from Europe that the incidence of LGIB is increasing and that mortality rates may be comparable to upper gastrointestinal bleeding (UGIB)4. LGIB may present as trivial bleeding requiring no inpatient investigation or treatment, or as life threatening ha ...
... and anorectal bleeding. There is some evidence from Europe that the incidence of LGIB is increasing and that mortality rates may be comparable to upper gastrointestinal bleeding (UGIB)4. LGIB may present as trivial bleeding requiring no inpatient investigation or treatment, or as life threatening ha ...
Screening for Varices and Prevention of Bleeding
... double-blinded trial showed that nonselective beta-blockers do not prevent the development of varices in the absence of demonstrable effect on HVPG and are associated with unwanted side effects. Individuals with compensated cirrhosis and absence of varices should undergo screening EGD every 2 to 3 y ...
... double-blinded trial showed that nonselective beta-blockers do not prevent the development of varices in the absence of demonstrable effect on HVPG and are associated with unwanted side effects. Individuals with compensated cirrhosis and absence of varices should undergo screening EGD every 2 to 3 y ...
Health Disparities - Texas Tech University Health Sciences Center
... • Number of non-institutionalized adults who currently have asthma: 16.4 million – % of non-institutionalized adults who currently have asthma: 7.3% ...
... • Number of non-institutionalized adults who currently have asthma: 16.4 million – % of non-institutionalized adults who currently have asthma: 7.3% ...
Heroin - Ireta
... age. Initiation to heroin was most likely to occur at 17 (15.6%) or 18 (18.6%) years of age. These adult patients had been using heroin on a daily basis prior to admission. They reported an average of six days a week of use, with most patients (82.4%) using seven days of the week. Other demographic ...
... age. Initiation to heroin was most likely to occur at 17 (15.6%) or 18 (18.6%) years of age. These adult patients had been using heroin on a daily basis prior to admission. They reported an average of six days a week of use, with most patients (82.4%) using seven days of the week. Other demographic ...
PHT Policy for the Safe Management of Injectable Medicines
... First level nurses will have established basic competencies in pre-registration education and competency will be maintained. If evidence cannot be produced, then further training should be ...
... First level nurses will have established basic competencies in pre-registration education and competency will be maintained. If evidence cannot be produced, then further training should be ...
Accidental Hypothermia
... clinicians should consider accessibility to an appropriate facility, local expertise, resources, and characteristics of the patient. When central venous access is required, it is important to keep the tip of the catheter (and guide wire) far from the heart in order to minimize the risk of arrhythmia ...
... clinicians should consider accessibility to an appropriate facility, local expertise, resources, and characteristics of the patient. When central venous access is required, it is important to keep the tip of the catheter (and guide wire) far from the heart in order to minimize the risk of arrhythmia ...
Cosmetic Lower Eyelid Blepharoplasty: Analysis
... Traditionally, lower lid blepharoplasty has been confined to a choice of skin or skin-muscle flap transcutaneous blepharoplasty. In the past decade, in particular, various new techniques and technologies have emerged, altering our ability to treat the lower eyelids. These techniques include transcon ...
... Traditionally, lower lid blepharoplasty has been confined to a choice of skin or skin-muscle flap transcutaneous blepharoplasty. In the past decade, in particular, various new techniques and technologies have emerged, altering our ability to treat the lower eyelids. These techniques include transcon ...
The Role of Subcutaneous Ketorolac for Pain Management
... observations of 36 inpatients with advanced malignant disease–associated pain treated with ketorolac CSI. All patients were receiving oral opioids. Prior to initiation of the ketorolac CSI at a rate of 60 mg over 24 hours, a verbal 4-point rating of the patient’s pain was obtained. Oral misoprostol ...
... observations of 36 inpatients with advanced malignant disease–associated pain treated with ketorolac CSI. All patients were receiving oral opioids. Prior to initiation of the ketorolac CSI at a rate of 60 mg over 24 hours, a verbal 4-point rating of the patient’s pain was obtained. Oral misoprostol ...
TAG Mail 13 January 2016 The purpose of TAG Mail is to assist TAG
... **The Laboratory of Innovative Practices on Polypharmacy and Health 3rd International Short Film and Photography Festival, May 2016 The participants' short films and photos should cover one of the following issues: - Primary health care understood as the essential health care accessible to all indiv ...
... **The Laboratory of Innovative Practices on Polypharmacy and Health 3rd International Short Film and Photography Festival, May 2016 The participants' short films and photos should cover one of the following issues: - Primary health care understood as the essential health care accessible to all indiv ...
Prescribing Information
... The number of subjects (n=10) ≥65 years old treated with CLARINEX-D 12 HOUR Extended Release Tablets was too limited to make any formal statistical comparison regarding the efficacy or safety of this drug product in this age group, or to determine whether they respond differently from younger subjec ...
... The number of subjects (n=10) ≥65 years old treated with CLARINEX-D 12 HOUR Extended Release Tablets was too limited to make any formal statistical comparison regarding the efficacy or safety of this drug product in this age group, or to determine whether they respond differently from younger subjec ...
A prospective clinical study of theophylline safety in 3810
... (COPD) who had been treated with sustained-release theophylline tablets (THEODURs) at a dose of 400 mg/day for 1–6 months, in principle. Among 3798 protocol-complying patients (mean age: 73.870.10 years, 1997 with COPD), 261 theophylline-related adverse events were observed in 179 (4.71%) patients. ...
... (COPD) who had been treated with sustained-release theophylline tablets (THEODURs) at a dose of 400 mg/day for 1–6 months, in principle. Among 3798 protocol-complying patients (mean age: 73.870.10 years, 1997 with COPD), 261 theophylline-related adverse events were observed in 179 (4.71%) patients. ...